Deregulation of Zeb1 activity has been implicated in multiple cancer types and, in these settings, Zeb1 acts as an instigator of the activity of cancer stem cells, a subset of cancer cells driving therapy resistance and metastasis, which ultimately cause fatality (42, 43). This evidence concerns the gene ZEB1 and cancer.